Education
About Us
Working with TipRanks
Follow Us
Lifestance Health Group (LFST)
NASDAQ:LFST
Earnings Data
Report Date
May 13, 2026After Close (Confirmed)
Period Ending
2026 (Q1)Consensus EPS Forecast
<0.01Last Year’s EPS
0Same Quarter Last Year
Strong Buy
Based on 8 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call highlights substantial progress in 2025: double-digit revenue and visit growth, clinician base expansion, meaningful productivity gains, record adjusted EBITDA margins, positive net income achieved early, strong free cash flow, and disciplined technology investments (including AI) driving operational improvements. Management provided constructive 2026 guidance with continued revenue and margin expansion and capital allocation optionality (share repurchase, disciplined M&A). The main headwinds are implementation costs and execution risk for a new EHR, ongoing competitive pressure for clinicians, a sizable stock-based compensation run rate in 2026, flat revenue per visit in the latest quarter, and the initial lower-margin impact of new center openings. Overall, the positive operational and financial momentum and clear path to margin expansion outweigh the manageable execution and market risks discussed.Company Guidance
Strong Revenue Growth
Full-year 2025 revenue of $1,424,000,000, up 14% year-over-year; Q4 2025 revenue of $382,000,000, up 17% year-over-year and modestly ahead of expectations.
Visit and Utilization Expansion
Nearly 9,000,000 visits in 2025 with Q4 visits of 2,400,000 (up 18% year-over-year). Visits per average clinician increased 7% year-over-year, reflecting productivity gains.
Clinician Growth and Scale
Net clinician adds of 657 in 2025, bringing the clinician base to 8,040 (9% year-over-year growth); Q4 net adds of 44. Clinician network delivered care to over 1,000,000 patients in 2025.
Record Profitability and Margin Expansion
Adjusted EBITDA for full-year 2025 of $158,000,000 (up 32% year-over-year) with margin of 11.1% (up 150 basis points). Q4 adjusted EBITDA of $49,000,000 (up 49% year-over-year) with a record Q4 margin of 12.8%, the highest as a public company.
Positive Net Income and EPS Milestone
Achieved positive net income and earnings per share for the full year 2025, reached one year ahead of prior expectations.
Strong Cash Generation and Balance Sheet
Free cash flow of $110,000,000 for full-year 2025 (exceeding expectations; up from $86,000,000 in 2024). Q4 free cash flow of $47,000,000. Cash balance of $249,000,000, net long-term debt of $266,000,000, undrawn revolver of $100,000,000, and net/gross leverage of 0.2x/1.8x.
Capital Deployment Optionality
Board authorized a $100,000,000 share repurchase program funded with cash on hand; M&A remains a priority with disciplined focus on smaller tuck-ins for geographic expansion (no material M&A included in 2026 guidance).
Technology and AI-Enabled Operational Gains
Targeted digital and AI solutions improved new patient booking conversion by ~5% (AI-assisted phone booking) and reduced clinician administrative burden via AI-assisted documentation pilots, contributing to productivity and revenue cycle improvements.
Clear 2026 Guidance and Long-Term Targets
2026 guidance: revenue $1.615B–$1.655B; center margin $526M–$550M; adjusted EBITDA $185M–$205M (midpoint margin ~11.9%). Company expects continued mid-teens revenue growth longer term and mid-teens adjusted EBITDA margins by fiscal 2028.
Specialty Services Growth Opportunity
Targeting ~$70,000,000 revenue from specialty services in 2026 (up ~40% from prior ~$50,000,000), driven by SPRAVATO and TMS, leveraging existing centers with low capital intensity.
LFST Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
LFST Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Feb 25, 2026 | $7.14 | $7.41 | +3.78% |
Nov 06, 2025 | $4.81 | $6.25 | +29.94% |
Aug 07, 2025 | $3.90 | $3.86 | -1.03% |
May 07, 2025 | $6.55 | $5.51 | -15.88% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Lifestance Health Group (LFST) report earnings?
Lifestance Health Group (LFST) is schdueled to report earning on May 13, 2026, After Close (Confirmed).
What is Lifestance Health Group (LFST) earnings time?
Lifestance Health Group (LFST) earnings time is at May 13, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is LFST EPS forecast?
LFST EPS forecast for the fiscal quarter 2026 (Q1) is <0.01.